John Tiller

1.7k total citations
56 papers, 1.1k citations indexed

About

John Tiller is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, John Tiller has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 22 papers in Pharmacology and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in John Tiller's work include Treatment of Major Depression (22 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (11 papers) and Electroconvulsive Therapy Studies (11 papers). John Tiller is often cited by papers focused on Treatment of Major Depression (22 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (11 papers) and Electroconvulsive Therapy Studies (11 papers). John Tiller collaborates with scholars based in Australia, Germany and New Zealand. John Tiller's co-authors include Jerzy Krupiński, Isaac Schweitzer, Graham D. Burrows, M. C. F. Pain, Brian Davies, Kay P. Maguire, Colleen Loo, K. Behnke, Colin Bouwer and Susan Waite and has published in prestigious journals such as CHEST Journal, Journal of Affective Disorders and Drugs.

In The Last Decade

John Tiller

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Tiller Australia 18 449 352 287 212 131 56 1.1k
M. Fava United States 11 351 0.8× 366 1.0× 263 0.9× 215 1.0× 122 0.9× 12 1.0k
Shamsah B. Sonawalla United States 19 364 0.8× 341 1.0× 278 1.0× 245 1.2× 128 1.0× 30 1.1k
Bill Lyndon Australia 16 853 1.9× 496 1.4× 350 1.2× 217 1.0× 178 1.4× 35 1.6k
J.C. Bisserbe France 21 302 0.7× 185 0.5× 392 1.4× 406 1.9× 212 1.6× 43 1.3k
Kristina Fritz Australia 17 638 1.4× 288 0.8× 281 1.0× 202 1.0× 130 1.0× 34 1.2k
Rajinder Judge United States 15 333 0.7× 421 1.2× 358 1.2× 354 1.7× 91 0.7× 17 1.1k
J.C. Ballenger United States 17 555 1.2× 426 1.2× 328 1.1× 273 1.3× 189 1.4× 174 1.7k
V.P. Kontaxakis Greece 21 640 1.4× 142 0.4× 317 1.1× 141 0.7× 125 1.0× 73 1.2k
Jean‐Pierre Lépine France 21 410 0.9× 311 0.9× 625 2.2× 426 2.0× 141 1.1× 56 1.6k
J M Perel United States 21 433 1.0× 331 0.9× 450 1.6× 263 1.2× 138 1.1× 31 1.3k

Countries citing papers authored by John Tiller

Since Specialization
Citations

This map shows the geographic impact of John Tiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tiller more than expected).

Fields of papers citing papers by John Tiller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Tiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tiller. The network helps show where John Tiller may publish in the future.

Co-authorship network of co-authors of John Tiller

This figure shows the co-authorship network connecting the top 25 collaborators of John Tiller. A scholar is included among the top collaborators of John Tiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Tiller. John Tiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hope, Judy, David Copolov, John Tiller, et al.. (2023). What clinicians need to know about intranasal esketamine for treatment-resistant depression?. Australasian Psychiatry. 31(6). 841–845. 7 indexed citations
2.
Newton, Richard, et al.. (2019). The challenges facing the public mental health sector: implications of the Victorian Psychiatry workforce project. Australasian Psychiatry. 27(6). 618–621. 4 indexed citations
3.
Ng, Bradley, et al.. (2019). Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Australian & New Zealand Journal of Psychiatry. 53(7). 609–623. 94 indexed citations
4.
Berk, Michael, John Tiller, Jun Zhao, et al.. (2015). Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes. The Journal of Clinical Psychiatry. 76(6). 728–734. 25 indexed citations
5.
Dodd, Seetal, Gin S. Malhi, John Tiller, et al.. (2011). A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder. Australian & New Zealand Journal of Psychiatry. 45(9). 712–725. 34 indexed citations
6.
Tiller, John. (2009). Tiller twenty-five years on. Rural Theology. 7(2). 121–125.
7.
Tiller, John, David Ames, Henry Brodaty, et al.. (2008). Antipsychotic use in the elderly: What doctors say they do, and what they do. Australasian Journal on Ageing. 27(3). 134–142. 6 indexed citations
8.
Keks, Nicholas A, Graham D. Burrows, David Copolov, et al.. (2007). Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?. The Medical Journal of Australia. 187(3). 198–200. 15 indexed citations
9.
Tiller, John, et al.. (2006). Seizure Threshold Determination for Electroconvulsive Therapy: Stimulus dose Titration Versus Age-Based Estimations. Australian & New Zealand Journal of Psychiatry. 40(2). 188–192. 31 indexed citations
10.
Ng, Chee H., Isaac Schweitzer, Panagiotis Alexopoulos, et al.. (2000). Efficacy and Cognitive Effects of Right Unilateral Electroconvulsive Therapy. Journal of Ect. 16(4). 370–379. 48 indexed citations
11.
Chiu, Edmond, et al.. (1999). An Open Study of Sertraline in Patients with Major Depression who Failed to Respond to Moclobemide. Australian & New Zealand Journal of Psychiatry. 33(6). 889–895. 3 indexed citations
12.
Tiller, John, et al.. (1999). Moclobemide and fluoxetine for panic disorder. European Archives of Psychiatry and Clinical Neuroscience. 249(S1). S7–S10. 36 indexed citations
13.
Burrows, Graham D. & John Tiller. (1999). Cade's observation of the antimanic effect of lithium and early Australian research. Australian & New Zealand Journal of Psychiatry. 33(s1). S27–S31. 3 indexed citations
14.
Schweitzer, Isaac, et al.. (1999). The Royal Melbourne Hospital Lithium Clinic. Australian & New Zealand Journal of Psychiatry. 33(s1). S35–S38. 3 indexed citations
15.
Tiller, John. (1999). Experimental and Clinical Pharmacology: The new antidepressants - clinical applications. Australian Prescriber. 22(5). 108–111. 2 indexed citations
16.
Tiller, John, et al.. (1998). Perception of Natural Fluctuations in Peak Flow in Asthma: Clinical Severity and Psychological Correlates. Journal of Asthma. 35(3). 251–259. 20 indexed citations
17.
Tiller, John, Gordon F. Johnson, & Graham D. Burrows. (1995). Moclobemide for Depression. Journal of Clinical Psychopharmacology. 15(4 Suppl 2). 31S–34S. 3 indexed citations
18.
Tiller, John. (1993). Clinical overview on moclobemide. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 17(5). 703–712. 14 indexed citations
19.
Maguire, K P, Virginia Tuckwell, I. Schweitzer, John Tiller, & Bronwyn Davies. (1990). Dexamethasone kinetics in depressed patients before and after clinical response. Psychoneuroendocrinology. 15(2). 113–123. 16 indexed citations
20.
Tiller, John, Kay P. Maguire, & Brian Davies. (1987). Tyramine pressor response with moclobemide— A reversible monoamine oxidase inhibitor. Psychiatry Research. 22(3). 213–220. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Fava Breakdown of academic impact, for papers by Shamsah B. Sonawalla Breakdown of academic impact, for papers by Bill Lyndon Breakdown of academic impact, for papers by J.C. Bisserbe Breakdown of academic impact, for papers by Kristina Fritz Breakdown of academic impact, for papers by Rajinder Judge Breakdown of academic impact, for papers by J.C. Ballenger Breakdown of academic impact, for papers by V.P. Kontaxakis Breakdown of academic impact, for papers by Jean‐Pierre Lépine Breakdown of academic impact, for papers by J M Perel
Rankless by CCL
2026